Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation

An ongoing Capitol Forum investigation of VITAS Healthcare, a subsidiary of Chemed (CHE) and the largest hospice provider in the nation, has found that the company is enrolling patients into hospice that do not meet Medicare guidelines and recording inaccurate diagnoses to avoid scrutiny from CMS. A hospice expert who reviewed internal VITAS assessment documents […]

Ligado Networks: Laura Loomer Calls Out Pentagon Official Steve Feinberg Over Alleged Conflict of Interest

President Donald Trump confidante and online provocateur Laura Loomer contends there is self- dealing involved in the government’s settlement talks with Ligado Networks centered around Deputy...

Aug 28, 2026 Read Now >

San Francisco Judge Denies California AG’s Motion for Preliminary Injunction Against Amazon’s Pricing Tactics, But Leaves Door Open for Per Se Scrutiny; Asks Parties to Consider Changing Trial Schedule

A San Francisco judge has rejected the California attorney general’s request for a preliminary injunction over alleged price-fixing by Amazon (AMZN), ruling that a trial will be necessary to...

Aug 28, 2026 Read Now >

Cintas/UniFirst: FTC Deepens Merger Investigation Through Expansive CIDs

FTC staff have in recent months issued civil investigative demands (CIDs) to third-party industry participants as the agency deepens its investigation into Cintas’ (CTAS) proposed $5.5 billion...

Aug 27, 2026 Read Now >

Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation

RELATED ARTICLES | Corporate investigations

Ligado Networks: Laura Loomer Calls Out Pentagon Official Steve Feinberg Over Alleged Conflict of Interest

San Francisco Judge Denies California AG’s Motion for Preliminary Injunction Against Amazon’s Pricing Tactics, But Leaves Door Open for Per Se Scrutiny; Asks Parties to Consider Changing Trial Schedule

Cintas/UniFirst: FTC Deepens Merger Investigation Through Expansive CIDs

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.